Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...

Life science laboratories saw a massive drop in demand last year after the NIH was forced to cancel billions of dollars in ...

Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...

Rosalind, to support research into biology, drug discovery and translational medicine. The model is built to improve scientific workflows by helping researchers analyze literature, generate hypotheses ...

OpenAI has unveiled GPT‑Rosalind, its first AI model tailored for life sciences, aimed at accelerating research in biology, drug discovery, and translational medicine. Named after DNA pioneer Rosalind ...

OpenAI have announced the early release of its new AI-powered life sciences application GPT-Rosalind to specific life science groups.

The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, ...

Rosalind, an AI model designed to accelerate drug discovery and support biology-related research work. Read more here.

OpenAI’s new research says AI and ChatGPT can accelerate life sciences, cut drug R&D delays, and bridge gaps slowing ...

A major life sciences and innovation project took its next step Oct. 9 in Camden. A slew of leaders, officials from all levels of government, and key stakeholders were on hand for the groundbreaking ...

Natasha Nikolaidis, MS, specializes in research operations and shared resource management, project and financial management, business planning, and strategic planning. She enhances research ...

OpenAI has launched GPT-Rosalind, a large language model tailored for life sciences, aiming to aid genomic analysis, experimental design, and drug discovery. The model shows leading performance on a ...